loan agreement
Revvity Enters Into $1.5B Credit Facility
The firm said that the unsecured $1.5 billion revolving credit facility through 2030 replaces another $1.5 billion credit facility through 2026.
VolitionRx Gets €5M Financing From Wallonie Entreprendre
The Nevada-based epigenetics firm will receive half the money through an unsecured loan and half through the sale of restricted common stock.
DeepUll Inks €20M Loan Agreement With European Investment Bank
The loan will finance DeepUll's research, development, and innovation efforts for its culture-free diagnostics platform for the early identification of sepsis.
Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement
Earlier this month, the Boulder, Colorado-based diagnostics firm reported ending the third quarter with $15.2 million in cash and cash equivalents.
VolitionRx Secures $1.5M Loan From Namur Invest Capital Risk
The non-dilutive funding will go toward an early-access program for Volition's Nu.Q nucleosome quantification technology in the US, EU, and UK.